[1]
Jackson, E.B. and Hotte, S.J. 2022. Disparity in public funding of systemic therapy for metastatic renal cell carcinoma within Canada. Canadian Urological Association Journal. 16, 11 (Jun. 2022), E516–22. DOI:https://doi.org/10.5489/cuaj.7846.